1 / 9

Global Biologics Outsourcing Market RationalStat

Innovative products and services such as nanobodies, rDNA, synthetic vaccines, and immunotherapeutics have emerged in the biologics industry in the last few years as part of the industryu2019s rapid expansion. Hybrid structures, which combine biologics with well-defined chemical entities, have had numerous opportunities to be explored in this industry.

JamesHenderson1819
Download Presentation

Global Biologics Outsourcing Market RationalStat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Biologics Outsourcing Market Growth, Opportunity & Analysis 2019-2028 2055 Limestone Rd STE 200-C, Wilmington, 19808 info@rationalstat.com +1 302-803-5429

  2. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 Table of Contents 1.Market Introduction 1.1.Scope of Study 1.2.Problem Statement 1.3.Market Segmentation 2.Assumptions and Acronyms 3.Executive Summary 3.1.Global Market in 2022 3.2.Analyst Insights & Recommendations 3.3.Growth Opportunities and Key Strategies 3.4.Supply-side and Demand-side Trends 4.Research Methodology 5.Analysis of COVID-19 Impact and Road Ahead 6.Market Indicators and Background 6.1.Macro-Economic Factors 6.2.Forecasting Factors Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions among others 6.3.Supply Chain & Value Chain Analysis 6.4.Industry SWOT Analysis 6.5.PESTLE Analysis 6.6.Porter’s Five Forces Analysis 7.Rules & Regulations 8.Global and Regional Market Dynamics 8.1.Drivers 8.2.Restraints 8.3.Trends 8.4.Opportunities 9.Global Biologics Outsourcing Market: Key Investment Analysis 9.1.By Leading Biologics Companies 9.2.Technological Assessment 9.3.By Region 9.4.M&A Activities Robust assessment of major investments made by various industry players along with key technological assessment, and key end-use sector 10.Global Biologics Outsourcing Market: Service Cost Analysis 10.1.By Service Type 10.1.1.Antibody Production Service 10.1.2.Custom Monoclonal Antibody Production Service 10.1.3.Custom Polyclonal Antibody Production Service 10.1.4.Protein Production Service 10.1.5.Gene Editing Service 11.Global Biologics Outsourcing Market: Biological Development Phase Analysis 11.1.Discovery 11.2.Pre-Clinical Click here to purchase online!

  3. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 11.3.Clinical 11.4.Commercialization 12.Parent Market Overview 12.1.Global Life Sciences Market 12.2.Global Healthcare Market 13.Segmental Analysis 13.1.Global Biologics Outsourcing Market by Product Type 13.1.1.Segment Overview 13.1.1.1.Antibodies 13.1.1.1.1.Monoclonal Antibody 13.1.1.1.2.Antibody Drug Conjugates 13.1.1.1.3.Others (Polyclonal Antibodies etc.) 13.1.1.2.Recombinant proteins 13.1.1.3.Vaccines 13.1.1.4.Others (Fusion Proteins, etc.) 13.2.Global Biologics Outsourcing Market by Source 13.2.1.Segment Overview 13.2.1.1.Human 13.2.1.2.Microbial 13.2.1.3.Others (Transgenic Animals such as Avian, Insects, etc.) 13.3.Global Biologics Outsourcing Market by Application 13.3.1.Segment Overview 13.3.1.1.Stem Cell Research 13.3.1.2.Vaccine and Therapeutics Development 13.3.1.3.Blood & Blood-Related Products Development 13.3.1.4.Cellular and Gene Therapy Products Development 13.3.1.5.Others (Tissue & Tissue Related Products Development) 13.4.Global Biologics Outsourcing Market by End Use 13.4.1.Segment Overview 13.4.1.1.Therapeutics and Diagnostics 13.4.1.2.Research 13.5.Global Biologics Outsourcing Market by Region 13.5.1.North America 13.5.2.Latin America 13.5.3.Western Europe 13.5.4.Eastern Europe 13.5.5.Asia Pacific 13.5.6.Middle East & Africa 14.Regional Analysis 14.1.North America Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.1.1.Market Overview 14.1.2.North America Biologics Outsourcing Market by Product Type 14.1.3.North America Biologics Outsourcing Market by Source 14.1.4.North America Biologics Outsourcing Market by Application 14.1.5.North America Biologics Outsourcing Market by End Use 14.1.6.North America Biologics Outsourcing Market by Country 14.1.6.1.US 14.1.6.2.Canada Click here to purchase online!

  4. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 14.2.Latin America Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.2.1.Market Overview 14.2.2.Latin America Biologics Outsourcing Market by Product Type 14.2.3.Latin America Biologics Outsourcing Market by Source 14.2.4.Latin America Biologics Outsourcing Market by Application 14.2.5.Latin America Biologics Outsourcing Market by End Use 14.2.6.Latin America Biologics Outsourcing Market by Country 14.2.6.1.Brazil 14.2.6.2.Mexico 14.2.6.3.Rest of Latin America 14.3.Western Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.3.1.Market Overview 14.3.2.Western Europe Biologics Outsourcing Market by Product Type 14.3.3.Western Europe Biologics Outsourcing Market by Source 14.3.4.Western Europe Biologics Outsourcing Market by Application 14.3.5.Western Europe Biologics Outsourcing Market by End Use 14.3.6.Western Europe Biologics Outsourcing Market by Country 14.3.6.1.Germany 14.3.6.2.UK 14.3.6.3.France 14.3.6.4.Spain 14.3.6.5.Italy 14.3.6.6.Benelux 14.3.6.7.Nordic 14.3.6.8.Rest of Western Europe 14.4.Eastern Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.4.1.Market Overview 14.4.2.Eastern Europe Biologics Outsourcing Market by Product Type 14.4.3.Eastern Europe Biologics Outsourcing Market by Source 14.4.4.Eastern Europe Biologics Outsourcing Market by Application 14.4.5.Eastern Europe Biologics Outsourcing Market by End Use 14.4.6.Eastern Europe Biologics Outsourcing Market by Country 14.4.6.1.Russia 14.4.6.2.Poland 14.4.6.3.Rest of Eastern Europe 14.5.Asia Pacific Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.5.1.Market Overview 14.5.2.Asia Pacific Biologics Outsourcing Market by Product Type 14.5.3.Asia Pacific Biologics Outsourcing Market by Source 14.5.4.Asia Pacific Biologics Outsourcing Market by Application 14.5.5.Asia Pacific Biologics Outsourcing Market by End Use 14.5.6.Asia Pacific Biologics Outsourcing Market by Country 14.5.6.1.China 14.5.6.2.Japan 14.5.6.3.India 14.5.6.4.South Korea 14.5.6.5.Australia 14.5.6.6.ASEAN Click here to purchase online!

  5. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 14.5.6.7.Rest of Asia-Pacific 14.6.Middle East & Africa Biologics Outsourcing Market Analysis and Forecast 2019-2028 14.6.1.Market Overview 14.6.2.Middle East & Africa Biologics Outsourcing Market by Product Type 14.6.3.Middle East & Africa Biologics Outsourcing Market by Source 14.6.4.Middle East & Africa Biologics Outsourcing Market by Application 14.6.5.Middle East & Africa Biologics Outsourcing Market by End Use 14.6.6.Middle East & Africa Biologics Outsourcing Market by Country 14.6.6.1.GCC 14.6.6.2.South Africa 14.6.6.3.Turkey 14.6.6.4.Rest of the Middle East & Africa 15.Competitive Landscape 15.1.Competition Dashboard 15.1.1.Global and Regional Market Share Analysis 15.1.2.Market Structure 15.2.Competitive Benchmarking 15.3.Key Strategy Analysis 15.4.Company Profiles 15.4.1.Lonza Group AG 15.4.1.1.Company Overview 15.4.1.2.Product/Service Offerings 15.4.1.3.Key Financials 15.4.1.4.Recent Developments 15.4.2.Wuxi Biologics (Cayman) Inc. 15.4.2.1.Company Overview 15.4.2.2.Product/Service Offerings 15.4.2.3.Financials 15.4.2.4.Recent Developments 15.4.3.Boehringer Ingelheim International GmbH 15.4.3.1.Company Overview 15.4.3.2.Product/Service Offerings 15.4.3.3.Financials 15.4.3.4.Recent Developments 15.4.4.Abzena Ltd. 15.4.4.1.Company Overview 15.4.4.2.Product/Service Offerings 15.4.4.3.Financials 15.4.4.4.Recent Developments 15.4.5.GL Biochem Corp. 15.4.5.1.Company Overview 15.4.5.2.Product/Service Offerings 15.4.5.3.Financials 15.4.5.4.Recent Developments 15.4.6.Catalent, Inc. 15.4.6.1.Company Overview 15.4.6.2.Product/Service Offerings 15.4.6.3.Financials Click here to purchase online!

  6. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 15.4.6.4.Recent Developments 15.4.7.Samsung Biologics Co.Ltd. 15.4.7.1.Company Overview 15.4.7.2.Product/Service Offerings 15.4.7.3.Financials 15.4.7.4.Recent Developments 15.4.8.ThermoFisher Scientific Inc. 15.4.8.1.Company Overview 15.4.8.2.Product/Service Offerings 15.4.8.3.Financials 15.4.8.4.Recent Developments 15.4.9.Syngene International Ltd. 15.4.9.1.Company Overview 15.4.9.2.Product/Service Offerings 15.4.9.3.Financials 15.4.9.4.Recent Developments 15.4.10.Rentschler Biopharma SE 15.4.10.1.Company Overview 15.4.10.2.Product/Service Offerings 15.4.10.3.Financials 15.4.10.4.Recent Developments 15.4.11.Abbvie Inc. 15.4.11.1.Company Overview 15.4.11.2.Product/Service Offerings 15.4.11.3.Financials 15.4.11.4.Recent Developments 15.4.12.Genscript Biotech Corp. 15.4.12.1.Company Overview 15.4.12.2.Product/Service Offerings 15.4.12.3.Financials 15.4.12.4.Recent Developments *List of companies is not exhaustive 16.Disclaimer Click here to purchase online!

  7. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 Increasing demand for highly efficient biotherapeutics from the value-centric patient population propels the market growth. Increasing demand for highly efficient biotherapeutics The market is expected to grow at a CAGR of 12.5%, driven by demand for highly efficient biotherapeutics The development is growing and is in the midst of numerous clinical studies. Outsourcing partners who have platforms and expertise, technology, expertise, experience are numerous companies to create cost-effective strategies. Biologics outsourcing market growth is likely to be constrained by the high cost of capital, technical, regulatory, and customer acquisition costs. rate of biological drug and by sought pharmaceutical Source: RationalStat Analysis Outsourcing biologics development and manufacturing to provide ample growth opportunities Market structure and competitive landscape focus on their core strengths. The Asia Pacific to hold a significant market share in forthcoming years Players operating in the global biologics outsourcing market focus on collaborations, acquisitions, and partnerships. Players are adopting various strategies to gain a competitive edge and first- mover advantage in the market. The Asia Pacific biologics outsourcing market is anticipated to grow due to the rising incidence of non-communicable diseases and increased demands for biologics. Additionally, the growth of the pharmaceutical industry in emerging markets and the increase in government initiatives to improve health facilities across economies in the region are driving the development of the biologics outsourcing market. The market for biologics needs for in-house biologics development and manufacturing capability. The manufacturing biopharmaceutical companies have prompted them to outsource various aspects development and manufacturing to efficient service suppliers. capabilities of According to the RationalStat analysis, prominent players contributing significantly to the global biologics outsourcing market include Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Abzena Limited, GL Biochem Corp., Catalent Inc., Samsung Biologics Co. Ltd., ThermoFisher Scientific Inc., Syngene International Ltd., Rentschler Biopharma SE, Abbvie Inc. and Genescript Biotech Corp., among others. of biologics Furthermore, outsourcing services to different organizations, such as contract research organizations (CROs) and manufacturers and contract companies (CDMOs), as well as contract manufacturing companies (CMOs), can allow large biopharmaceutical companies to reduce their operating costs and Global companies are investing significant amounts in China and India, outsourcing their research and development for biologics, which is a significant factor of growth to the overall market. Click here to purchase online!

  8. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 Global Biologics Outsourcing Market Analysis & Forecast by Product Type, 2019-2028 (US$ Million) Breakup by Breakup by Product Product Type Type 2019(H) 2019(H) 2020(H) 2020(H) 2021(H) 2021(H) 2022(E) 2022(E) 2023(F) 2023(F) 202 2024 4(F) (F) 20 2025 25(F) (F) 202 2026 6(F) (F) 2027 2027(F) (F) 2028 2028(F) (F) XX XX XX XX XX XX XX XX XX XX Antibodies XX XX XX XX XX XX XX XX XX XX Vaccines Recombinant Proteins XX XX XX XX XX XX XX XX XX XX Others (Fusion Proteins, etc.) XX XX XX XX XX XX XX XX XX XX Total Total XX XX XX XX XX XX XX XX XX XX Global Biologics Outsourcing Market Breakup by Region, 2022 (%) XX% XX% XX% XX% XX% XX% Click here to purchase online!

  9. Global Biologics Outsourcing Market Growth, Opportunity & Analysis, 2019-2028 Sources considered for the report Primary Sources •Extensive primary interviews were conducted during the research study. Over 120 industry specialists were contacted while conducting the research study to gather market insights. The primary interviews have been conducted with specialists across the value chain ranging from the service providers to end users, across the globe. Secondary Sources •Annual reports, company filings, investor presentations, product catalogs, white papers, research reports, trade fairs, Robotic Industries Association, International Federation of Robotics, and company documents. •Available industry and market-related documents in the public domain. •Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, Thomson Reuters, among others. •Whitepapers, research papers, and industry blogs Why buy this report? The report provides an in-depth analysis of market size, consumption pattern, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions. The report is intended for pharmaceutical companies, biotechnology and biologics companies, healthcare facilities, government organizations, educational organizations, regulatory agencies, and market research firms, among others. About RationalStat LLC RationalStat is a global market intelligence partner dedicated to offer in-depth insight and recommendations to a varied clientele of medium and large-sized corporations. We provide cost-effective, accurate, and insightful business intelligence to our clients within tight timeframes. We offer a host of comprehensive market research reports, industry trackers, macroeconomic research, and subscription services, covering many sectors. Our team of accomplished sectoral analysts, economists, and industry specialists produce comprehensive analysis and rigorous market studies to guide investment decisions and growth strategies. For Procurement, unlike many other research solutions on the market today, RationalStat caters directly to procurement professionals. Our research follows a consistent table of contents, meaning you can easily find what you need. Contact us RationalStat LLC 2055 Limestone Rd STE 200-C, Wilmington, DE 19808, USA Web: rationalstat.com Call: +1 302-803-5429 Email: info@rationalstat.com Click here to purchase online!

More Related